Celebrex (celecoxib) might increase the risk of bleeding in patients taking warfarin
June 1999
Searle is now warning that Celebrex (celecoxib) might increase the risk of bleeding in patients taking warfarin.
Celebrex is the new COX-2 inhibitor for arthritis.
It decreases joint pain and swelling...without some of the adverse effects that are caused by NSAIDs.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote